Glycerin

Glycerin

SCHEMBL9706702

Nc1ccccc1N.OCC(O)CO

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.53
ALOX15 P16050 2/20 0.53
CASP1 P29466 1/20 0.53
CASP7 P55210 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
ALDH1A1 P00352 5/20 0.47
LMNA P02545 3/20 0.47
TSHR P16473 3/20 0.42
CYP1A2 P05177 4/20 0.39
KDM4E B2RXH2 3/20 0.39
AGTR1 P30556 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
HSD17B10 Q99714 2/20 0.39
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
CYP2C19 P33261 2/20 0.37
ADRA2A P08913 1/20 0.37
ADRA2B P18089 1/20 0.37
ADRA2C P18825 1/20 0.37
MAPT P10636 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Questiomycin B SCHEMBL28074074 0.86 ALOX15 (0.65) CYP3A4ALOX15CASP1CASP7SMN1; SMN2
Aniline SCHEMBL27572633 0.82 TSHR (0.55) CYP3A4ALDH1A1LMNATSHRCYP1A2
SCHEMBL10693501 0.80 FDPS (0.38) CYP3A4ALOX15CASP1CASP7SMN1; SMN2
Glycerin SCHEMBL28051395 0.80 HDAC3 (0.39) ALOX15SMN1; SMN2ALDH1A1LMNACYP1A2
Anthranilic Acid SCHEMBL1672125 0.80 MAPT (0.48) CYP3A4ALOX15CASP7SMN1; SMN2ALDH1A1
Glycerin SCHEMBL4965821 0.78 ALDH1A1 (0.53) CYP3A4ALOX15CASP1SMN1; SMN2ALDH1A1
Naphthalene SCHEMBL28132028 0.78 LMNA (0.53) ALDH1A1LMNATSHRCYP1A2KDM4E
SCHEMBL27830279 0.77 TSHR (0.33) CYP3A4ALOX15CASP1CASP7SMN1; SMN2
SCHEMBL5835220 0.77 MEN1 (0.54) CYP3A4ALOX15SMN1; SMN2ALDH1A1LMNA
Catechol SCHEMBL27780229 0.76 ALDH1A1 (0.56) CYP3A4ALOX15SMN1; SMN2ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992022638-A1 PERILIPIN THE UNITED STATES OF AMERICA REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES (US) 1992-12-23 WO disclosed